Maland Secures Medical Device Registration for Non-Invasive Brain-Computer Interface TMS System Following Two Consecutive Daily Trading Limits

(Source: Caiwen)

MedlanderBrain-Computer Interface Transcranial Magnetic Stimulator Obtains Medical Device Registration Certificate. Among them, the brain-computer module is used to monitor physiological parameters such as human electroencephalographic signals and changes in hemoglobin concentration due to hemodynamic responses, displaying brain status data through dynamic imaging.

News on January 9, according to the official website of Jiangsu Provincial Drug Administration,Medlander (688273.SH)Brain-Computer Interface Transcranial Magnetic Stimulator Obtains Medical Device Registration Certificate.

The registration certificate shows that the product has a magnetic stimulation module and a brain-computer module. The magnetic stimulation module stimulates the central and peripheral nerves of the human body, and is used for the detection, evaluation, and improvement of the functions of the central and peripheral nervous systems (including the pelvic floor), as well as for the auxiliary treatment of nerve injury diseases and lumbosacral nerve dysfunction. The brain-computer module is used to monitor physiological parameters such as human electroencephalographic signals and changes in hemoglobin concentration related to hemodynamic responses, displaying brain status data through dynamic imaging.

Notably, on January 5 and January 6, Medlander Medical Technology Inc. consecutively achieved two "20CM" limit-up trading surges, ranking among the top in brain-computer interface concept stocks. In terms of news, Medlander previously announced that it is expected to obtain the first medical device registration certificate for a brain-computer interface (Transcranial Magnetic Stimulation Device) in the first quarter of 2026, at which time it will accelerate integration into its existing product line. Now, the Transcranial Magnetic Stimulation Device for brain-computer interface has obtained the medical device registration certificate, which means that Medlander has taken a substantial step forward in the industrial application of non-invasive brain-computer interfaces, with subsequent commercialization expected to speed up.

Data shows that Medlander, established in 2013, is a provider of physical rehabilitation intervention technology solutions for women throughout their entire life cycle in China. The company mainly engages in the research and development, production, sales, and service of related products. Focusing on the diagnosis, treatment, and prevention of common and frequently-occurring diseases during the female life cycle, the company continuously develops new technologies and products. It now has product lines including pelvic floor and postpartum rehabilitation equipment, reproductive rehabilitation equipment, consumables and accessories, and health management information systems, which are widely used in medical and health fields such as obstetrics and gynecology, pelvic floor rehabilitation, reproductive rehabilitation, urology and proctology, and physical examinations.

In the research and development of brain-computer interface products, according to Medlander's 2025 semi-annual report, the company is exploring other cutting-edge application fields of brain-computer interfaces. Currently, it has launched major project collaborations, including those under China’s National Key Research and Development Plan, with several universities and research institutes such as Nanjing Medical University, Southeast University, and Zhejiang University. These efforts focus on applying EEG, near-infrared, and other technologies to address issues like neurodegenerative diseases, emotional cognition, and stroke-related neural rehabilitation.

In addition,Yijiahe(Maintenance of Rights)（603666.SH）Also hopped on the brain-computer interface bandwagon. On January 5, Yijiahe Technology CO.,LTD stated that the company is actively exploring cutting-edge technologies including "brain-computer interface" and embodied intelligence.RobotTechnological integration: Medlander has signed a strategic cooperation agreement to jointly explore the application possibilities of "brain-computer interface + embodied intelligent robot" technology in scenarios such as intelligent health care. Affected by this, Yijiahe Technology CO.,LTD also achieved a limit-up on the same day.

It is reported that Yijiahe Technology CO.,LTD. is a robotic intelligent application service provider dedicated to the research, development, production, and promotion of robotic applications. Yijiahe was listed on the A-share main board in 2018 and has since established research and development centers/branches in Nanjing, Shenzhen, Songshan Lake, Hong Kong, Singapore, the United States, and other locations, gradually building a global presence. Currently, Yijiahe has completed the first application of embodied intelligent humanoid robots in high-risk energy scenarios and continues to make significant advancements in high-end elderly care and home scenarios. In the future, the company aims to become a globally leading enterprise in embodied intelligent humanoid robotics, continuously driving technological progress and innovation within the industry.

Previously, Huayuan Securities stated that the cooperation between Medlander and Yijiahe Technology CO.,LTD. is divided into three phases: short-term, medium-term, and long-term. The collaboration ranges from technical integration and exploring the application of brain-computer interface (BCI) in robot motion control and health monitoring functions, to jointly launching products and solutions. For instance, by analyzing functional near-infrared spectroscopy signals, early warnings for potential risks such as stroke can be provided. Medlander's BCI series of products are expected to be fully implemented in health and wellness scenarios.